Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $483.97 million as of May 5, 2026. Its market cap has increased by 92.82% in one year.

Market Cap

483.97M

Enterprise Value

913.95M

1-Year Change

92.82%

Ranking

#3178

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $483.97M, an increase of 50.86%. That is a compound annual growth rate of 2.13%.

Market Cap History

Date	Market Cap	% Change
May 4, 2026	440.60M	-32.12%
Dec 31, 2025	649.10M	25.31%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%
Nov 15, 2006	320.80M	-

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Esperion Therapeutics	803.10M
Ironwood Pharmaceuticals	748.44M
BioAge Labs	737.89M
Tilray Brands	703.77M
Aquestive Therapeutics	524.48M
Kamada	477.57M
Canopy Growth	426.50M
Akebia Therapeutics	401.85M

Market Cap Rankings